Curated News
By: NewsRamp Editorial Staff
April 24, 2025
Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth
TLDR
- Appointments of seasoned executives bring valuable experience and leadership to Helix BioPharma, enhancing competitive edge in oncology industry.
- Veronika Kandziora and Jessica Kourniaktis join Helix BioPharma as COO and Director of Communications, respectively, to strengthen organizational structure and communication strategies.
- Helix BioPharma's focus on developing novel therapies for hard-to-treat cancers aims to deliver better treatment options and improve patient outcomes, making the world a better place.
- Ms. Kandziora's financial industry background and Ms. Kourniaktis' academic expertise bring diverse perspectives to Helix BioPharma, shaping a dynamic and innovative environment.
Impact - Why it Matters
This news highlights the strategic moves made by Helix BioPharma Corp. to strengthen its leadership team and enhance communication efforts. The appointments of Kandziora and Kourniaktis signify a pivotal stage in Helix's development, signaling a determined focus on achieving its goals in the fight against hard-to-treat cancers. The expertise brought by these key players will play a significant role in shaping the future of oncology treatments.
Summary
Helix BioPharma Corp. announced the appointments of Veronika Kandziora as Chief Operating Officer and Jessica Kourniaktis as Director of Communications. Kandziora brings over 20 years of leadership experience in biopharma, finance, and consulting to her role. Kourniaktis, with a background in the Humanities, has 10 years of experience in the life sciences. Both will play crucial roles in advancing Helix's mission against hard-to-treat cancers.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth
